Global Cardiac Implants Market Research Report Forecast till 2023

Published - Jul 2019 | Category - Pharma & Healthcare | No. of Pages - 164 | Published By - Market Research Future

Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Overview
4.2 Drivers
4.2.1 Rising prevalence of cardiac diseases
4.2.2 Increasing geriatric population
4.3 Restraints
4.3.1 High cost of cardiac implants
4.3.2 Risk of infection due to cardiac implants
4.4 Opportunities
4.4.1 Technological advancements in cardiac implants
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intense Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
6 Global Cardiac Implants Market, by Device
6.1 Overview
6.2 Cardiac Rhythm Management Devices
6.3 Coronary Stents
6.4 Prosthetic Heart Valve Devices
6.5 Ventricular Assist Devices
6.6 Implantable Loop Recorder/Implantable Cardiac Monitor
6.7 Others
7 Global Cardiac Implants Market, by Indication
7.1 Overview
7.2 Arrhythmias
7.3 Myocardial Ischemia
7.4 Acute Myocardial Infarction
7.5 Heart Failure
7.6 Others
8 Global Cardiac Implants Market, by End User
8.1 Overview
8.2 Hospitals
8.3 Cardiac Care Centers
8.4 Ambulatory Centers & Home Care
8.5 Academic Institutes
8.6 Others
9 Global Cardiac Implants Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 UK
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Introduction
10.2 Company Share Analysis
11 Company Profile
11.1 Abbott
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offered
11.1.4 SWOT Analysis
11.1.5 Key Developments
11.1.6 Key Strategy
11.2 Amg International
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offered
11.2.4 SWOT Analysis
11.2.5 Key Developments
11.2.6 Key Strategy
11.3 Edwards Lifesciences Corporation
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offered
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 B. Braun Melsungen AG
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products/Services Offered
11.4.4 SWOT Analysis
11.4.5 Key Developments
11.4.6 Key Strategy
11.5 Biotronik
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products/Services Offered
11.5.4 SWOT Analysis
11.5.5 Key Developments
11.5.6 Key Strategy
11.6 Boston Scientific Corporation
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products/Services Offered
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 LivaNova PLC
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products/Services Offered
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Medtronic Plc
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products/Services Offered
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 SynCardia Systems, Inc.
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products/Services Offered
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Terumo Corporation
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products/Services Offered
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print
 

Quick Buy